AssetMemo
AssetsMechanismsCompaniesCalendarChartsWatchlistAsk AIMethodology
  • Cardiovascular & Metabolic469
  • Dermatology230
  • Gastroenterology & Hepatology177
  • Hematology45
  • Immunology176
  • Infectious Disease145
  • Nephrology130
  • Neurology478
  • Oncology1,186
  • Ophthalmology75
  • Psychiatry141
  • Rare & Genetic Diseases141
  • Respiratory162
◧AssetMemo
⌕

Evidence-graded drug-asset intelligence
◧AssetMemo
AssetsMechanismsCompaniesReadout CalendarCompare ChartsWatchlist & AlertsAsk AI
Therapeutic areas
  • Cardiovascular & Metabolic469
  • Dermatology230
  • Gastroenterology & Hepatology177
  • Hematology45
  • Immunology176
  • Infectious Disease145
  • Nephrology130
  • Neurology478
  • Oncology1,186
  • Ophthalmology75
  • Psychiatry141
  • Rare & Genetic Diseases141
  • Respiratory162
ReferenceMethodology & RubricUs vs. AI ToolsUK IBD Access GuideAbout the founder

Educational data tool. Evidence graded; securities never are.

BrowseAll assetsAll mechanismsAll companiesReadout calendarReadouts by yearResults by diseaseDelayed readoutsOpen dataCompare share pricesWhat's new
ReferenceMethodology & sourcesUs vs. the AI toolsUK IBD Access GuideAbout the founderAsk the AIReport a problem / suggest a feature

Educational research only, not investment advice. Evidence quality is graded; securities never are. · Terms · Privacy · Logos by Logo.dev

Ask

Opening the console…

Every target, every pathway

1,560 mechanisms of action. Filter by indication or lead stage, then open one to see the drugs that act on it.

← browse by therapeutic area

1560 of 1560 mechanisms

GLP-1 receptor
GLP-1 receptor agonistAtherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Heart Failure (+7 more)
Assets51
Lead stageApproved
EGFR
EGFR tyrosine kinase inhibitorBreast Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma (+5 more)
Assets42
Lead stageApproved
KRAS G12D
KRAS G12D-directedAdvanced Solid Tumors, Non-Small Cell Lung Cancer, Pancreatic Cancer (+1 more)
Assets42
Lead stagePhase 3
VEGF-A
VEGF-A inhibitorAdvanced Metastatic Colorectal Cancer, Age-Related Macular Degeneration, Cervical Cancer (+10 more)
Assets39
Lead stageApproved
Activin/myostatin type II receptor
Activin type II receptor signaling blocker…Obesity, Spinal Muscular Atrophy
Assets34
Lead stagePhase 3
BCMA
BCMA-directed therapy (B-cell maturation a…Multiple Myeloma
Assets30
Lead stageApproved
PD-1
Anti-PD-1 checkpoint inhibitorAdvanced Colorectal Cancer, Advanced Metastatic Colorectal Cancer, Biliary Tract Cancer (+26 more)
Assets27
Lead stageApproved
Dopamine D2 and serotonin 5-HT2A receptors (antagonist)
atypical antipsychoticBipolar Depression, Bipolar Disorder, Major Depressive Disorder (+1 more)
Assets23
Lead stageApproved
Glucocorticoid receptor
Selective glucocorticoid receptor modulatorAllergic Conjunctivitis, Amyotrophic Lateral Sclerosis, Asthma (+9 more)
Assets23
Lead stageApproved
TNF-alpha
Anti-TNF inhibitorCrohn's Disease, Hidradenitis Suppurativa, Non-Infectious Uveitis (+4 more)
Assets23
Lead stageApproved
Dopamine D3/D2 and serotonin 5-HT1A receptors (partial agonist)
Dopamine D3/D2 and serotonin 5-HT1A recept…Bipolar Depression, Schizophrenia
Assets19
Lead stagePhase 3
PCSK9
PCSK9-targeted therapeuticAtherosclerotic Cardiovascular Disease, Dyslipidemia, Homozygous Familial Hypercholesterolemia (+3 more)
Assets19
Lead stageApproved
Tissue Factor (TF)
Tissue Factor-directed antibody-drug conju…Advanced Solid Tumors, Cervical Cancer, Non-Small Cell Lung Cancer
Assets18
Lead stageApproved
Beta-2 adrenergic receptor
Beta-2 adrenergic receptor agonistAsthma, Chronic Obstructive Pulmonary Disease
Assets17
Lead stageApproved
CD19
CD19-directed (binds CD19 on B cells)Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma (+9 more)
Assets17
Lead stageApproved
CD70
CD70-directedAcute Myeloid Leukemia, Myelodysplastic Syndromes
Assets17
Lead stagePhase 2
DPP-4
Dipeptidyl peptidase-4 inhibitorType 2 Diabetes
Assets17
Lead stageApproved
HER2
HER2-directed therapyAdvanced Metastatic Colorectal Cancer, Biliary Tract Cancer, Breast Cancer (+11 more)
Assets17
Lead stageApproved
5-HT1B/1D receptor
Triptan (5-HT1B/1D receptor agonist)Migraine
Assets16
Lead stageApproved
CD20
Anti-CD20 monoclonal antibodyB-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma (+12 more)
Assets16
Lead stageApproved
GABA-A receptor
GABA-A receptor positive allosteric modulatorDevelopmental and Epileptic Encephalopathies, Dravet Syndrome, Epilepsy (+4 more)
Assets15
Lead stageApproved
HIV reverse transcriptase
Non-nucleoside reverse transcriptase inhib…COVID-19, HIV
Assets14
Lead stageApproved
CD38
Anti-CD38 monoclonal antibodyAL Amyloidosis, Chronic Kidney Disease, IgA Nephropathy (+4 more)
Assets13
Lead stageApproved
GLP-1/GIP receptor (dual)
Dual GLP-1/GIP receptor agonistAlcohol Use Disorder, Asthma, Atherosclerotic Cardiovascular Disease (+15 more)
Assets13
Lead stageApproved
IL-23 p19
IL-23 inhibitorCrohn's Disease, Psoriasis, Psoriatic Arthritis (+1 more)
Assets13
Lead stageApproved
Insulin receptor (basal)
Basal insulin analogType 1 Diabetes, Type 2 Diabetes
Assets13
Lead stageApproved
KRAS G12C
KRAS G12C covalent inhibitorAdvanced Metastatic Colorectal Cancer, Colorectal Cancer, Metastatic Colorectal Cancer (+1 more)
Assets13
Lead stageApproved
MET
MET (c-Met)-directedAdvanced Metastatic Colorectal Cancer, Colorectal Cancer, Glioma (+3 more)
Assets13
Lead stageApproved
PD-L1
anti-PD-L1 monoclonal antibodyAlzheimer's Disease, Biliary Tract Cancer, Bladder Cancer (+15 more)
Assets13
Lead stageApproved
TYK2
TYK2 inhibitorAtopic Dermatitis, Crohn's Disease, Hidradenitis Suppurativa (+8 more)
Assets13
Lead stageApproved
BCMA x CD3
BCMA x CD3 T-cell engagerAL Amyloidosis, Lupus Nephritis, Multiple Myeloma (+1 more)
Assets12
Lead stageApproved
IL-4R-alpha
Anti-IL-4Ralpha monoclonal antibodyAsthma, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease (+3 more)
Assets11
Lead stageApproved
Muscarinic acetylcholine receptor (M3)
Muscarinic M3 receptor antagonist (anticho…Asthma, Chronic Obstructive Pulmonary Disease
Assets11
Lead stageApproved
NMDA receptor
NMDA receptor antagonistMajor Depressive Disorder, Parkinson's Disease
Assets11
Lead stageApproved
PDE4
Phosphodiesterase-4 inhibitorAtopic Dermatitis, Chronic Obstructive Pulmonary Disease, Cognitive Impairment Associated with Schizophrenia (+5 more)
Assets11
Lead stageApproved
SGLT2
Sodium-glucose cotransporter-2 inhibitorAtherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Heart Failure (+1 more)
Assets11
Lead stageApproved
BCL-2
Small molecule BCL-2 inhibitorAcute Myeloid Leukemia, Chronic Lymphocytic Leukemia, HR+/HER2- Metastatic Breast Cancer (+4 more)
Assets10
Lead stageApproved
dopamine precursor
Levodopa-based dopamine replacementParkinson's Disease
Assets10
Lead stageApproved
JAK1
oral JAK1 inhibitorAlopecia Areata, Asthma, Atopic Dermatitis (+7 more)
Assets10
Lead stageApproved
Aminosalicylate
AminosalicylateRheumatoid Arthritis, Ulcerative Colitis
Assets9
Lead stageApproved
Amyloid-beta (monoclonal antibody)
Anti-amyloid-beta monoclonal antibodyAlzheimer's Disease, Early Alzheimer's Disease
Assets9
Lead stageApproved
ANGPTL3
ANGPTL3 inhibitorAtherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Homozygous Familial Hypercholesterolemia (+2 more)
Assets9
Lead stageApproved
EGFR x c-MET
Dual EGFR and MET targetingAdvanced Metastatic Colorectal Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma (+1 more)
Assets9
Lead stageApproved
Estrogen receptor
small moleculeBreast Cancer, HR+/HER2- Metastatic Breast Cancer
Assets9
Lead stageApproved
GLP-1/glucagon receptor (dual)
Dual GLP-1/glucagon receptor agonistMASH / NASH, Obesity, Type 2 Diabetes
Assets9
Lead stagePhase 3
HIV integrase
Integrase strand transfer inhibitor (INSTI)HIV
Assets9
Lead stageApproved
Insulin receptor
InsulinType 1 Diabetes, Type 2 Diabetes
Assets9
Lead stageApproved
Transthyretin (TTR)
Anti-transthyretin monoclonal antibodyHeart Failure, Transthyretin Amyloidosis with Cardiomyopathy, Transthyretin Amyloidosis with Polyneuropathy
Assets9
Lead stageApproved
TSLP
Anti-TSLP monoclonal antibodyAsthma, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease (+1 more)
Assets9
Lead stageApproved
5-HT2A receptor
Serotonergic psychedelicAttention Deficit Hyperactivity Disorder, Generalized Anxiety Disorder, Major Depressive Disorder (+2 more)
Assets8
Lead stagePhase 3
Amylin receptor
Amylin receptor agonistChronic Kidney Disease, Obesity, Osteoarthritis (+2 more)
Assets8
Lead stageApproved
APOC3
APOC3 siRNAFamilial Chylomicronemia Syndrome, Hypertriglyceridemia, Severe Hypertriglyceridemia
Assets8
Lead stageApproved
B7-H3
B7-H3-directed antibody-drug conjugate (to…Esophageal Squamous Cell Carcinoma, Metastatic Castration-Resistant Prostate Cancer, Nasopharyngeal Carcinoma (+3 more)
Assets8
Lead stagePhase 3
Cardiac cell therapy
Cell-based regenerative therapyDuchenne Muscular Dystrophy, Heart Failure, Ischemic Heart Failure
Assets8
Lead stagePhase 3
Cereblon E3 ubiquitin-ligase
small moleculeFollicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma (+1 more)
Assets8
Lead stageApproved
CFTR
CFTR potentiatorCystic Fibrosis
Assets8
Lead stageApproved
IL-12 p40
IL-12/23 inhibitorCrohn's Disease, Psoriasis, Psoriatic Arthritis (+1 more)
Assets8
Lead stageApproved
IP receptor (prostacyclin pathway)
Prostacyclin pathway agonistIdiopathic Pulmonary Fibrosis, Pulmonary Arterial Hypertension, Pulmonary Hypertension Associated with Interstitial Lung Disease (+1 more)
Assets8
Lead stageApproved
No discrete molecular target
No single molecular target (whole-cell, vi…Atherosclerotic Cardiovascular Disease, Melanoma, Non-Small Cell Lung Cancer (+1 more)
Assets8
Lead stageApproved
Pan-KRAS
Colorectal Cancer, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma
Assets8
Lead stagePhase 1/2
S1P receptor
S1P receptor modulatorCrohn's Disease, Multiple Sclerosis, Psoriasis (+1 more)
Assets8
Lead stageApproved
TL1A
Anti-TL1A monoclonal antibodyAtopic Dermatitis, Crohn's Disease, Hidradenitis Suppurativa (+3 more)
Assets8
Lead stagePhase 3
TROP2
TROP2-directedBladder Cancer, Breast Cancer, Cervical Cancer (+5 more)
Assets8
Lead stageApproved
Type I interferon receptor
InterferonChronic Hepatitis B, Essential Thrombocythemia, Follicular Lymphoma (+4 more)
Assets8
Lead stageApproved
Aldosterone synthase (CYP11B2)
Aldosterone synthase inhibitorChronic Kidney Disease, Heart Failure, Hypertension (+1 more)
Assets7
Lead stageApproved
Complement C5
Complement C5 inhibitor (RNA aptamer)Age-Related Macular Degeneration, Generalized Myasthenia Gravis, IgA Nephropathy (+3 more)
Assets7
Lead stageApproved
dopaminergic neuron replacement
stem cell-derived dopaminergic neuron repl…Parkinson's Disease
Assets7
Lead stagePhase 2
GPRC5D
GPRC5D-directedMultiple Myeloma
Assets7
Lead stagePhase 3
HER3
HER3 (ERBB3)-directedBreast Cancer, HR+/HER2- Metastatic Breast Cancer, Non-Small Cell Lung Cancer (+1 more)
Assets7
Lead stagePhase 3
HIF prolyl hydroxylase (HIF-PH1/2/3)
HIF prolyl hydroxylase inhibitor (HIF-PHI)Chronic Kidney Disease, Myelodysplastic Syndromes
Assets7
Lead stageApproved
HIV envelope
Broadly neutralizing antibodyHIV
Assets7
Lead stagePhase 3
IRAK4
Oral IRAK4 chimeric degradation-activating…Acute Myeloid Leukemia, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease (+4 more)
Assets7
Lead stagePhase 2
JAK
Janus kinase (JAK) inhibitorAlopecia Areata, Atopic Dermatitis, COVID-19 (+8 more)
Assets7
Lead stageApproved
Voltage-gated sodium channel
Voltage-gated sodium-channel blockerBipolar Disorder, Developmental and Epileptic Encephalopathies, Epilepsy (+2 more)
Assets7
Lead stageApproved
ALK
ALK-Positive Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Assets6
Lead stageApproved
CDK2
novel selective CDK2 inhibitorBreast Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer
Assets6
Lead stagePhase 3
CDK4 and CDK6
CDK4/6 inhibitor (small molecule)Breast Cancer, Glioma, HER2-Positive Breast Cancer (+1 more)
Assets6
Lead stageApproved
Dopamine D2/D3 and serotonin 5-HT1A receptor
Serotonin-dopamine activity modulator (ant…Alzheimer's Disease, Bipolar Disorder, Major Depressive Disorder (+1 more)
Assets6
Lead stageApproved
HBV polymerase (reverse transcriptase)
Nucleoside analogue HBV polymerase inhibitorChronic Hepatitis B
Assets6
Lead stageApproved
HDAC
Colorectal Cancer, Cutaneous T-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (+6 more)
Assets6
Lead stageApproved
HIV capsid
Capsid inhibitorHIV
Assets6
Lead stageApproved
MAPT mRNA (RNAi/ASO)
Tau (MAPT)-lowering RNAi/antisense oligonu…Alzheimer's Disease, Progressive Supranuclear Palsy
Assets6
Lead stagePhase 3
Nectin-4
Nectin-4-directed drug conjugate (delivers…Bladder Cancer, Cervical Cancer, HR+/HER2- Metastatic Breast Cancer (+2 more)
Assets6
Lead stageApproved
Nonsteroidal Anti-inflammatory Drug
Cyclooxygenase InhibitorsMigraine
Assets6
Lead stageApproved
PRMT5
MTA-cooperative PRMT5 inhibitorClassical Hodgkin Lymphoma, Glioblastoma, Non-Small Cell Lung Cancer (+1 more)
Assets6
Lead stagePhase 1/2
Serotonin 5-HT2A receptor (antagonist / inverse agonist)
5-HT2A inverse agonistAlzheimer's Disease, Alzheimer's Disease Psychosis, Atherosclerotic Cardiovascular Disease (+3 more)
Assets6
Lead stageApproved
Soluble guanylate cyclase
Soluble guanylate cyclase stimulatorChronic Kidney Disease, Focal Segmental Glomerulosclerosis, Heart Failure (+3 more)
Assets6
Lead stageApproved
5-HT1D receptor
Ergot alkaloid 5-HT1D receptor agonist (al…Migraine
Assets5
Lead stageApproved
alpha-synuclein
Alpha-synuclein-directed (targets patholog…Parkinson's Disease
Assets5
Lead stagePhase 3
Angiotensinogen (AGT)
Antisense oligonucleotide (AGT-lowering)Hypertension
Assets5
Lead stagePhase 3
BTK
BTK inhibitorAsthma, Chronic Graft-versus-Host Disease, Chronic Lymphocytic Leukemia (+7 more)
Assets5
Lead stageApproved
Cardiac myosin (inhibitor)
Selective cardiac myosin inhibitorHeart Failure, Heart Failure with Preserved Ejection Fraction, Hypertrophic Cardiomyopathy
Assets5
Lead stageApproved
CCR8
Anti-CCR8 monoclonal antibodyNon-Small Cell Lung Cancer
Assets5
Lead stagePhase 2
CD123
CD123-targeted recombinant fusion protein …Acute Myeloid Leukemia
Assets5
Lead stagePhase 2/3
CD20 x CD3
T-cell engaging bispecific antibodyB-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma (+4 more)
Assets5
Lead stageApproved
CD33
CD33-directedAcute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia
Assets5
Lead stageApproved
CD73
CD73 inhibitorMultiple Myeloma, Non-Small Cell Lung Cancer
Assets5
Lead stagePhase 3
CDK4
Selective CDK4 inhibitor (small molecule)HR+/HER2- Metastatic Breast Cancer
Assets5
Lead stagePhase 3
CGRP receptor
CGRP receptor antagonistMigraine
Assets5
Lead stageApproved
Dopamine D3/D2 receptor (partial agonist)
Dopamine partial agonistBipolar Depression, Bipolar Disorder, Major Depressive Disorder (+1 more)
Assets5
Lead stageApproved